ストックスクリーナーアプリを入手
2.05
0.49%
0.010
プレマーケット:
2.03
-0.02
-0.98%
前日終値:
$2.04
開ける：
$2.09
24時間の取引高:
39,832
Relative Volume:
0.02
時価総額：
$3.43M
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-5.09%
1か月 パフォーマンス:
+42.66%
6か月 パフォーマンス:
+44.47%
1年 パフォーマンス:
+65.90%
1日の値動き範囲:
$2.02
$2.1027
1週間の範囲:
$1.83
$2.245
52週間の値動き範囲:
$0.84
$2.778
Entero Therapeutics Inc Stock (ENTO) Company Profile
ENTO を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ENTO
Entero Therapeutics Inc
|
2.05 | 3.43M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
388.94 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.38 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
443.64 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
677.32 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
308.63 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Entero Therapeutics Inc (ENTO) 最新ニュース
Is it too late to sell Entero Therapeutics Inc.Market Volume Report & AI Enhanced Trading Alerts - Newser
Trendlines Suggest Entero Therapeutics Inc. May Bottom Out SoonTrade Exit Summary & Verified High Yield Trade Plans - thegnnews.com
Price action breakdown for Entero Therapeutics Inc.July 2025 Big Picture & Smart Swing Trading Alerts - Newser
Detecting support and resistance levels for Entero Therapeutics Inc.Trade Exit Summary & Verified Entry Point Signals - Newser
Is Entero Therapeutics Inc. meeting your algorithmic filter criteriaMarket Performance Summary & Low Drawdown Trading Techniques - Newser
Applying Elliott Wave Theory to Entero Therapeutics Inc.Portfolio Risk Summary & High Win Rate Trade Tips - Newser
Entero Therapeutics Announces Reverse Stock Split - MSN
Is now a turning point for Entero Therapeutics Inc.2025 Technical Overview & Smart Investment Allocation Insights - Newser
Using portfolio simulators with Entero Therapeutics Inc. included2025 Valuation Update & Long Hold Capital Preservation Tips - Newser
News impact scoring models applied to Entero Therapeutics Inc.Weekly Profit Report & Expert Approved Momentum Trade Ideas - Newser
Long term hold vs stop loss in Entero Therapeutics Inc.Quarterly Earnings Report & Real-Time Volume Trigger Notifications - Newser
Should you wait for a breakout in Entero Therapeutics Inc.2025 Valuation Update & Trade Opportunity Analysis Reports - Newser
Combining machine learning predictions for Entero Therapeutics Inc.July 2025 Update & High Yield Stock Recommendations - Newser
Entero Therapeutics Inc. Stages Intraday Comeback — Trend Change2025 Earnings Impact & Smart Allocation Stock Tips - 선데이타임즈
Trendlines Converge — Decision Point for Entero Therapeutics Inc.July 2025 Retail & Long-Term Growth Stock Strategies - 선데이타임즈
Top Risks to Consider Before Buying Entero Therapeutics Inc. StockWeekly Loss Report & Weekly Hot Stock Watchlists - Newser
Momentum divergence signals in Entero Therapeutics Inc. chartEntry Point & High Accuracy Swing Trade Signals - Newser
Is this a good reentry point in Entero Therapeutics Inc.2025 Geopolitical Influence & Advanced Technical Analysis Signals - Newser
Entero Therapeutics Implements Reverse Stock Split to Maintain Nasdaq Listing - AInvest
Entero Therapeutics to effect 1 for 3 reverse stock split, trading on Nasdaq on August 18. - AInvest
How sentiment analysis helps forecast Entero Therapeutics Inc.July 2025 Movers & Accurate Intraday Trading Signals - Newser
What makes Entero Therapeutics Inc. stock price move sharplyEarnings Summary Report & Low Risk High Win Rate Picks - thegnnews.com
Entero Therapeutics, Inc. SEC 10-Q Report - TradingView
Entero Therapeutics stock falls after announcing reverse stock split By Investing.com - Investing.com Nigeria
Entero Therapeutics stock falls after announcing reverse stock split - Investing.com
Entero Therapeutics announces 1-for-3 reverse stock split By Investing.com - Investing.com Nigeria
Entero Therapeutics, Inc. Announces Reverse Stock Split | ENTO Stock News - GuruFocus
Entero Therapeutics announces 1-for-3 reverse stock split - Investing.com India
Entero Therapeutics Implements Reverse Stock Split to Regain Nasdaq Compliance - AInvest
Entero Therapeutics Plans 1:3 Reverse Split as Shares Drop Below Nasdaq Minimum - Stock Titan
Is Entero Therapeutics Inc. a Top Dividend Stock to Watch in 2025Earnings Risk Report & Detailed Earnings Play Strategies - Newser
Reversal Traders Monitor Entero Therapeutics Inc. for EntryM&A Rumor & Verified Momentum Stock Watchlist - beatles.ru
Entero Therapeutics Inc (ENTO) 財務データ
Entero Therapeutics Inc (ENTO) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
Entero Therapeutics Inc (ENTO) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Romano Sarah | Chief Financial Officer |
Oct 09 '24 |
Sale |
0.45 |
476 |
212 |
18,014 |
1.38%
0.27%
大文字化:
|
ボリューム (24 時間):